Journal article
Basic cancer research is essential for the success of personalised medicine
European Journal of Cancer, Vol.49(12), pp.2619-2620
Aug/2013
Abstract
The last decade has witnessed significant progress in cancer understanding and therapy: we can now identify the genetic drivers of individual tumours, and tailor drugs able to specifically intercept the driver mutations. While all agree that personalised cancer medicine is a clear outcome of the resources dedicated to cancer research over the last 50 years, some critics question the necessity for continuous investments in sub-fields other than clinical research and drug development. Herein, scientists from the European Association for Cancer Research (EACR) argue that the new ways to diagnose and treat cancer present important and hitherto unaddressed challenges for fundamental research of cancer. Allocating the resources needed for basic studies will likely fuel the next wave of achievements in the long way to conquer cancer. (C) 2013 Elsevier Ltd. All rights reserved.
Details
- Title
- Basic cancer research is essential for the success of personalised medicine
- Creators
- Yosef Yarden (null) - The Weizmann Institute of ScienceCarlos Caldes (null)
- Resource Type
- Journal article
- Publication Details
- European Journal of Cancer, Vol.49(12), pp.2619-2620; Aug/2013
- Number of pages
- 2
- Language
- English
- DOI
- https://doi.org/10.1016/j.ejca.2013.04.020
- Record Identifier
- 993266137703596
Metrics
5 Record Views